Last Updated On 4/19/2023 11:19:39 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
No Relationships to Disclose |
|
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Exelixis |
Recipient: Your Institution |
Company: Merck |
Recipient: Your Institution |
Company: QED Therapeutics |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: Clovis Oncology, Inc. |
Recipient: You |
Company: AstraZeneca Pharmaceuticals LP |
Recipient: You |
Company: PROCEPT BioRobotics Corporation |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
No Relationships to Disclose |
|
|